CRM -6.2% on Jun 2: Salesforce Guidance Cut Drags S&P 500 Software Cohort
Salesforce (CRM) fell 6.18% to $196.64 by 11:07 AM ET on June 2 after cutting FY27 revenue guidance roughly 180 bps below FactSet consensus, dragging NOW, ADBE, and HUBS
Breaking News
Breaking US market news, SEC 8-K filings, mega-cap moves, and macro events as they happen. Real-time alerts on Fed decisions, geopolitical risks, earnings surprises, and sector rotations that move markets — published within minutes of the original event.
Breaking News
Real-time market alerts for significant moves — VIX spikes, index crashes/surges, mega-cap shocks, and macro surprises.
31 articles
CRM Stock Surges 10.4% to $210.98 on Jun 1: Gap-Up Leads S&P 500
CRM jumped 10.4% to $210.98 by 11:20 AM ET on Jun 1, leading S&P 500 gap-ups. With VIX at 15.3 and 10Y at 4.45%, the move tests June risk appetite.
ORCL +6.0%: ServiceNow Jumps as AI Fears Ease — Jun 1 Market Reaction
Oracle surged 6.04% to $239.42 at 11:03 AM ET on June 1 after CEO Safra Catz flagged accelerating OCI backlog into FY27 — ServiceNow +4.8%, MongoDB +3.1%. With
Why Stocks Are Moving Jun 1: S&P 500 Slips 0.11% on Jun 1 as VIX Jumps 4.6%, Energy +1.33%
S&P 500 -0.11% at 7,571.64 hides 9/11 red sectors and a VIX +4.57% pop to 16.02. Energy +1.33% and Tech +0.73% are the only green spots as the 10Y pushes to 4.47% — a
CRM +8.5% on May 31: Benioff Calls $11.1B Q1 a ‘Sign’ as Salesforce Bounces From
Salesforce (CRM) trades at $191.12, up 8.49% at 11:02 AM ET on May 31 after a $11.1B fiscal Q1 print and Benioff calling the quarter a ‘sign.’ The gap matters less than
MSFT Jumps 5.4% to $450 on May 31 After Invesco Summit Fund Q1 Disclosure
Microsoft tagged $450.24 at 5:18 AM ET Sunday on a 1.2M-share ECN print after Invesco Summit Fund’s Q1 disclosure hit EDGAR. The 5.44% gap is positioning, not re-rating
META 8-K Filed May 29, 2026: Monday Open Risk With VIX at 15.7
META filed a Form 8-K on May 29 into a tape with VIX at 15.7 and 10Y at 4.45%. Watch Monday’s open: low vol means gap risk is asymmetric.
AMZN Falls 2.4% on May 23 Following SEC 8-K Filing Disclosure
AMZN falls 2.4% following an SEC 8-K filing as investors weigh the implications of structural changes on margins. Here is the May 23 analysis.
MRK +5.7%: Merck (MRK) Phase 3 TroFuse-005 Trial for Endometrial Cancer Meets
Merck (MRK) surged 5.7% to $122.43 as Phase 3 TroFuse-005 trial met primary endpoints, triggering an oncology sector rotation amid a 4.57% 10Y yield environment.
AMD -5.7%: AMD Server Share Gains Test The Strength Of Its AI Growth Story — May
AMD shares dropped 5.7% on May 16, 2026, as market concerns about server market share and macro headwinds hit the AI sector. Analysis of the move and the path forward.